#Taiwan #Las Vegas #biotechnology #SynbioTech #TWK10

SynbioTech: Bringing Taiwan's Probiotic Innovation to the World

Taiwan's Synbio Tech Inc. has emerged as a leading player in the biopharmaceutical industry, distinguished by its groundbreaking probiotic, Lactiplantibacillus plantarum TWK10®. Having gained acclaim on the global stage, SynbioTech is set to showcase this innovative product at the esteemed SupplySide Global 2025, which will take place from October 27 to 30. The company will occupy Booth #6253F, where it will share substantial findings about TWK10® and its health benefits.

The TWK10® strain has undergone extensive clinical validation, proving its efficacy in enhancing muscle strength, endurance, and balance. These attributes are particularly important for both younger active individuals and older adults who strive to maintain a vigorous lifestyle. Research suggests that TWK10® can improve endurance by as much as 20-40%, while also promoting muscle mass gains between 0.5 to 1 kg. Moreover, the strain supports overall strength, recovery, and mobility throughout different stages of life.

Clinical Validation and Recognition

Underpinned by over a decade of dedicated research, TWK10® has become a cornerstone in gut–muscle axis studies, with its findings celebrated in the scientific community. One pivotal study was recognized by Wiley as a “Top Cited Article,” an accolade that underscores the significance of TWK10® in advancing microbiome research.

The global reach of TWK10® is bolstered by its recognition across various regulatory frameworks. It has achieved U.S. GRAS Self-Affirmed status, received health-functional food approval in Korea, and garnered Health Food certification in Taiwan with an anti-fatigue claim. Additional registrations in Malaysia and Thailand further cement its status as a trusted probiotic in the global market. A recent authorization from Japan's Food for Specified Health Uses (FFC) marks a significant milestone, positioning TWK10® among the most clinically validated probiotics for muscle health available worldwide.

A Commitment to Microbiome Science

Chuan-Hsien Yang, Chief Operating Officer of SynbioTech, elaborates on the company's mission: “For SynbioTech, it’s more than just a product; it’s a commitment to demonstrating how microbiome science can genuinely enhance quality of life. TWK10® represents the culmination of years of research that harmoniously blends traditional Taiwanese fermentation techniques with cutting-edge clinical applications.”

As SynbioTech works to extend its global collaborations and research partnerships, the aim is to bridge Asian healthcare innovations with international health markets. The initiative reflects an aspiration to empower individuals toward healthier lifestyles through the science of microbiome.

About Synbio Tech Inc.

Founded in 2000, Synbio Tech has carved a niche as a global leader in probiotic and postbiotic research, offering microbiome-based health solutions. With over 25 years of R&D experience and an integrated CDMO platform, the company collaborates with a diverse array of over 600 brands across 35 countries. Their mantra, “From Strain to Solution,” encapsulates the transformative potential of probiotics in improving people's lives.

For those interested in learning more about this innovative company, additional details can be found at synbiotech.com.